Clinical trial
Myeloma X Relapse (Intensive): A Phase III Study to Determine the Role of a Second Autologous Stem Cell Transplant as Consolidation Therapy in Patients With Relapsed Multiple Myeloma Following Prior High-dose Chemotherapy and Autologous Stem Cell Rescue.
NCT00747877 is registered in ClinicalTrials.gov with Leeds Cancer Centre at St. James's University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Myeloma X Relapse (Intensive): A Phase III Study to Determine the Role of a Second Autologous Stem Cell Transplant as Consolidation Therapy in Patients With Relapsed Multiple Myeloma Following Prior High-dose Chemotherapy and Autologous Stem Cell Rescue.
- Lead sponsor
- Leeds Cancer Centre at St. James's University Hospital
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- April 30, 2008
- Completion date
- Not reported
- Enrollment
- 460 (estimated)
- Sites
- 53
Conditions
As the registry lists them; a condition with its own page is linked.
multiple myeloma and plasma cell neoplasm